Results 131 to 140 of about 48,009 (234)

Mixed Medullary-Follicular Carcinoma of the Thyroid [PDF]

, 1999
Mixed medullary-follicular thyroid carcinoma is an uncommon tumor that consists of both follicular and parafollicular cells. Case.We report a 43-year-old woman with a palpable mass in the right side of the neck.
Bahmanyar, Mohammad, Eghbali, Seyed Sajjad, Pourbehi, Gholamreza, Tohidi, Maasumeh   +3 more
core  

Sex Matters: Hormonal and Chromosomal Determinants of Autoimmunity and Anti‐Cancer Immunity Across the Lifespan

Immunological Reviews, Volume 338, Issue 1, March 2026.
ABSTRACT Sex plays a key role in shaping both anti‐cancer immunity and autoimmunity. Biological factors underlying sexual dimorphism have now been identified in multiple aspects of anti‐cancer immunity and autoimmunity. These factors include sex differences in hormone levels, chromosome complement, and expression of the long non‐coding RNA XIST.
Christian G. Bustillos, Esther M. Peluso, Sophia L. Cha, Melissa G. Lechner, Maureen A. Su   +4 more
wiley   +1 more source

Emerging role of multikinase inhibitors for refractory thyroid cancer

Biologics: Targets & Therapy, 2012
Cesar A Perez,1 Belisario A Arango,1 Michel Velez,1 Luis E Raez,2 Edgardo S Santos11University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center, Miami, USA; 2Memorial Cancer Institute, Memorial Health Care System, Hollywood, FL ...
Perez CA, Arango BA, Velez M, Raez LE, Santos ES   +4 more
doaj  

RET proto-oncogene and thyroid cancer [PDF]

, 2018
TheRET proto-oncogene has not only conclusively been identified as responsible for the three subtypes of the inherited cancer syndrome multiple endocrine neoplasia type 2 (MEN-2) but also shown to be involved in the molecular evolution of sporadic ...
Komminoth, Paul
core  

If treating obesity with GLP‐1‐based therapies protects the heart, could it also prevent cancer or improve cancer outcomes? The case for randomized trials

Diabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 1599-1602, March 2026.
Anastasios Tentolouris, Ioannis Ntanasis‐Stathopoulos   +1 more
wiley   +1 more source

Sorafenib for the treatment of metastatic thyroid cancer patients [PDF]

, 2011
Segons resultats de fases II amb inhibidors tirosina quinasa i el coneixement de les alteracions moleculars de la carcinogènesis tiroïdal, es va dissenyar un estudi retrospectiu de pacients amb càncer de tiroide metastàtic tractats amb sorafenib.
Capdevila Castillón, Jaume, Galcerán, Joan Carles, Universitat Autònoma de Barcelona. Departament de Cirurgia, Universitat Autònoma de Barcelona. Departament de Medicina, Universitat Autònoma de Barcelona. Facultat de Medicina   +4 more
core   +1 more source

Prophylactic thyroidectomy in ethnic Chinese patients with multiple endocrine neoplasia type 2A syndrome after the introduction of genetic testing [PDF]

, 2009
Objective: To evaluate the impact of genetic testing in the management of familial multiple endocrine neoplasia 2A patients. Design: Retrospective study. Setting: University teaching hospital, Hong Kong.
GarciaBarcelo, MM, Lam, KSL, Lang, BHH, Lau, GSK, Lo, CY, Tam, PK, Tso, A   +6 more
core  

Medullary Thyroid Cancer

, 2022
Trofimiuk-Müldner, Małgorzata, Domagała, Bartosz, Hubalewska-Dydejczyk, Alicja   +2 more
openaire   +3 more sources

Laboratory diagnostics and follow-up of medullary thyroid cancer. [PDF]

J Mol Endocrinol
Giovanella L, D'Aurizio F, Petranović Ovčariček P, Hillebrand JJ.   +3 more
europepmc   +1 more source

Pembrolizumab in recurrent or metastatic medullary thyroid cancer. [PDF]

Oncologist
Del Rivero J, Donahue RN, Marte JL, Gramza A, Cordes L, Karzai F, Abel ML, Schlom J, Gulley JL, Madan RA.   +9 more
europepmc   +1 more source